B-Cell Non-Hodgkin Lymphoma Clinical Trials in New York, New York

5 studies are recruiting for b-cell non-hodgkin lymphoma in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

    This is a Phase 2 global, multi-center, open-label study to assess the efficacy, safety and tolerability of surovatamig (AZD0486) monotherapy in adult participants with relapsed/refractory B-cell non-Hodgkin lymphoma (NHL) who have received at least two prior lines of therapies. The study has 2 Mod…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Research Site, New York, New York
    Locations
    94 in total
    Run by
    AstraZeneca

    See if you can join NCT06526793 on ClinicalTrials.gov

  2. A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

    The purpose of this study is to assess the safety and efficacy of surovatamig (formerly AZD0486) administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, New York, New York
    Locations
    65 in total
    Run by
    AstraZeneca

    See if you can join NCT06564038 on ClinicalTrials.gov

  3. A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

    This is a Phase I/II open-label, global multicenter study to evaluate the safety and efficacy of AZD4512 monotherapy or in combination with other anticancer agent(s), in participants with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma (B-NHL).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, New York, New York
    Locations
    23 in total
    Run by
    AstraZeneca

    See if you can join NCT07123454 on ClinicalTrials.gov

  4. A Study of ARC-02 in B-cell NHL

    This study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    NYU Langone, New York, New York
    Locations
    29 in total
    Run by
    Taiho Oncology, Inc.

    See if you can join NCT07691606 on ClinicalTrials.gov

  5. A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

    This clinical trial is designed to assess the safety, preliminary efficacy, and pharmacokinetics (PK) of DS3790a monotherapy and combination regimens in participants with hematological malignancies.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, New York, New York
    Locations
    8 in total
    Run by
    Daiichi Sankyo

    See if you can join NCT07220616 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.